<qa>  What is the STUDY OF CC-5013 TO EVALUATE SAFETYSTUDY OF CC-5013 TO EVALUATE SAFETY, PHARMACOKINETICS AND EFFECTIVENESS FOR JAPANESE PATIENTS WITH SYMPTOMATIC ANEMIA ASSOCIATED WITH MYELODYSPLASTIC SYNDROME WITH A DEL5Q31-33 ABNORMALITY.: 